Skip to main content
. Author manuscript; available in PMC: 2020 Dec 9.
Published in final edited form as: Circ Heart Fail. 2019 Dec 9;12(12):e006231. doi: 10.1161/CIRCHEARTFAILURE.119.006231

Figure 2. Distribution of pathogenic and likely pathogenic variants in the primary (Panel A, n=178) and exploratory (Panel B, n=34) cohorts.

Figure 2.

Figure 2.

Compound heterozygosity was seen in five primary cohort participants who carried variants in MYBPC3 in addition to MYH7 (n=4) or TNNT2 (n=1) variants.